Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells

Pancreatic cancer (PanC) is one of the most lethal malignancies, and resistance towards gemcitabine, the front-line chemotherapy, is the main cause for dismal rate of survival in PanC patients; overcoming this resistance remains a major challenge to treat this deadly malignancy. Whereas several mole...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Oncol
Päätekijät: SOMASAGARA, RANGANATHA R., DEEP, GAGAN, SHROTRIYA, SANGEETA, PATEL, MANISHA, AGARWAL, CHAPLA, AGARWAL, RAJESH
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2015
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356502/
https://ncbi.nlm.nih.gov/pubmed/25672620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2015.2885
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia